Image

Complex Ocular Infection, Optimization of Microbiological Diagnosis

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to evaluate the impact of different technique to optimize the microbiological diagnosis of the COI.

  • Metagenomic for the endophtalmitis
  • Multiplex polymerase chain reaction for corneal abscesses

Description

Microbiological diagnosis of complex ocular infection (COI) (i.e: endophtalmitis and corneal abscess) is a current challenge. Indeed, endophtalmitis are often germ-free because a lack of microbiological diagnosis due to small volume to analyze and a complex site to attain. The microbiological etiologies of corneal abscesses are more frequently identified.

Since few years, new molecular tools are developed in infectious diseases to optimizing the microbiological diagnosis. The investigators implemented these techniques in our hospital to optimize the microbiological diagnosis of complex ocular infection (COI). Thus, endophtalmitis benefit, when the volume of the ocular sample is sufficient, of molecular techniques (16s PCR and metagenomic shotgun). Corneal abscesses could shortly benefit of multiplex PCR in order to reduce the time to diagnosis.

The impact and accuracy of these techniques is unknown.

Eligibility

Inclusion Criteria:

  • Adult patient
  • Patient presenting or having presented a clinical suspicion of complex ocular infection requiring a sample for microbiological diagnosis:
    • Corneal abscess requiring hospitalization
    • Any suspicion of endogenous or exogenous endophthalmitis.
  • Patient not opposed to participating in the research

Exclusion Criteria:

  • Patient under guardianship or curatorship
  • Pregnant women

Study details

Endophthalmitis, Keratitis

NCT05432336

Assistance Publique - Hôpitaux de Paris

7 June 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.